GSK acquired an experimental therapy from Chimagen Biosciences, paying $300 million upfront for the “T-cell engager” therapy, ...

Jade Biosciences, a privately held developer of immune disease drugs, will combine with Aerovate Therapeutics in a reverse merger that gives Jade a fast pass to trade on public markets. Prior to the ...

BRENTFORD, Britain (AP) — BRENTFORD, Britain (AP) — GSK plc (GSK) on Wednesday reported a loss of $75.4 million in its third quarter. The Brentford, Britain-based company said it had a loss of ...

This implies year-on-year profit growth of around 10 per cent. GSK (GSK) used its third quarter trading update to draw a definitive line under the damaging litigation around its now discontinued ...

Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...

The startup, Crescent Biopharma, on Tuesday announced a reverse merger with GlycoMimetics, a struggling, publicly traded developer of oncology and inflammatory disease drugs. In support of the deal, ...

The merger was cleared by US competition regulators ... Unlike its other big UK rival GlaxoSmithKline, AstraZeneca has impressed investors with its rich pipeline, which has been behind the ...

Capri, the parent company of fashion brands Michael Kors and Jimmy Choo, saw its stock tank nearly 50% on Friday after a federal judge blocked its pending $8.5 billion merger with Coach owner ...

Tapestry claims the proposed merger is both pro-competitive and pro-consumer. Tapestry has to act fast since there is a February 2025 deadline for the expiration of the bonds intended for the ...

Southern District of New York judge Jennifer Rochon granted the FTC's motion for a preliminary injunction to block the proposed merger on the grounds that a combination would hurt competition and ...